3Indexed trials
drug · Product Intelligence
Methotrexate
Pipeline Intelligence
Methotrexate: 3 indexed trials, 3 sponsors; 0 linked Orange Book patents and 11 FDA-linked events where matched.
3Sponsors
0Orange Book patent links
11FDA-linked events
Development evidence
NCT04239859Singapore General Hospital · out_of_scopePHASE4
NCT04571697Janssen Research & Development, LLC · alzheimersCOMPLETED
NCT06260904All India Institute of Medical Sciences, Bhubaneswar · out_of_scopePHASE4
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALMETHOTREXATE SODIUM · 2026-04-30
FDA_APPROVALMETHOTREXATE SODIUM · 2024-05-16
FDA_APPROVALMETHOTREXATE SODIUM · 2015-05-21
FDA_APPROVALMETHOTREXATE SODIUM PRESERVATIVE FREE · 2012-02-27
FDA_APPROVALMETHOTREXATE SODIUM PRESERVATIVE FREE · 2009-03-31
FDA_APPROVALMETHOTREXATE SODIUM PRESERVATIVE FREE · 2009-03-31
FDA_APPROVALTREXALL · 2001-03-21
FDA_APPROVALMETHOTREXATE SODIUM · 1992-05-15
FDA_APPROVALFOLEX PFS · 1991-08-23
FDA_APPROVALMEXATE-AQ · 1985-02-14
FDA_APPROVALFOLEX · 1983-04-08
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.